Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- GLD Partners, LP, with a growing footprint of investments in life sciences, healthcare, and biotech, today announced the successful acquisition of...
 - 
                            
Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
 - 
                            
Brabant Development Agency (BOM) and angel investor join lead investor Libertatis Ergo Holding (LEH) in providing funding, with additional financial support from Brabant Startup Fund (BSF)Cantoni...
 - 
                            
Burlingame, CA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Global Vitamin D Therapy Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, exhibiting a...
 - 
                            
Delray Beach, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Mullings Group Companies (“TMG”), a global leader in talent access for MedTech, HealthTech, and Life Sciences, today announced the official...
 - 
                            
Lumanity launches Expert-Directed Applied Intelligence (EDAI) platform to engineer value, enhance agility and illuminate innovation.
 - 
                            
DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT, the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North...
 - 
                            
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
 - 
                            
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- BioNTX, the leading voice of the bioscience and healthcare innovation ecosystem in North Texas, is proud to announce its attendance at the upcoming 2025 BIO...
 - 
                            
Lumanity announces a new partnership to accelerate the lab to bedside journey for cancer patients with the Parker Institute for Cancer Immunotherapy.